-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MDK-701 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MDK-701 in Solid Tumor Drug Details: MDK-701 is under development for the treatment of solid...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Mirdametinib in Low-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mirdametinib in Low-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mirdametinib in Low-Grade Glioma Drug Details: mirdametinib (PD-0325901) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pacmilimab in Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pacmilimab in Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pacmilimab in Adenocarcinoma Drug Details: CX-072 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mitoxantrone Hydrochloride in Nasopharyngeal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Mitoxantrone Hydrochloride in Nasopharyngeal Cancer Drug Details: Mitoxantrone hydrochloride is a anthracenedione antibiotic with antineoplastic activity....
-
Product Insights
MDA-MBH-MDK Field, Indonesia
MDA-MBH-MDK Field is a producing field located in East Java, Indonesia. It is being operated by Husky-CNOOC Madura Ltd. Empower your strategies with our MDA-MBH-MDK Field, Indonesia report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance....
-
Product Insights
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Interleukin 7 Receptor Subunit Alpha Pipeline Drugs Market Report Overview Interleukin-7 receptor is a protein found on the surface of cells. It acts as a receptor for thymic stromal lymphopoietin (TSLP) and plays an important role in T-cell acute lymphoblastic leukemia, multiple sclerosis, rheumatoid arthritis, and juvenile idiopathic arthritis. The Interleukin 7 Receptor Subunit Alpha pipeline drugs market research report provides comprehensive information on the Interleukin 7 Receptor Subunit Alpha targeted therapeutics, complete with analysis by indications, stage of development,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MDK-701
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry MDK-701 Drug Details MDK-701 is under development for the treatment of solid tumors. The...
-
Track & Monitor
Indonesia MDA-MBH-MDK Project Panorama – Oil and Gas Upstream Analysis Report
Indonesia MDA-MBH-MDK Project Panorama, GlobalData’s latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential.